Literature DB >> 9314368

Treatment of malignant superior vena cava obstruction: metal stents or radiation therapy.

A A Nicholson1, D F Ettles, A Arnold, M Greenstone, J F Dyet.   

Abstract

PURPOSE: The results of treating malignant superior vena cava obstruction by means of percutaneous self-expanding stent insertion or by means of radiation therapy were compared. PATIENTS AND METHODS: Seventy-six patients with malignant superior vena cava obstruction who were treated by stent insertion were studied prospectively and 25 patients who were treated by radiation therapy were studied retrospectively. A superior vena cava obstruction score was devised to measure treatment effectiveness. Speed of symptom relief and complications were recorded. End points in the study were recurrent obstruction or death. Asymptomatic survival times were compared by log rank and Mann Whitney tests of significance, as well as Kaplan-Meier analysis. A subgroup of 26 patients who were treated by stent placement only were compared with the radiation therapy group and analyzed separately.
RESULTS: There were seven complications in the overall stent group, one in the stent-only group, and 25 in the radiation therapy group. Stent insertion provided faster relief of symptoms and significantly greater improvement in the superior vena cava obstruction score than radiation therapy (P < .001, Mann-Whitney U test). A Kaplan-Meier analysis of asymptomatic survival demonstrated that significantly fewer patients in the overall and stent-only groups developed recurrent symptoms (P = .0005 and .001, respectively, log rank test).
CONCLUSION: This study suggests that percutaneous stent insertion in malignant superior vena cava obstruction fulfills the requirements of a palliative procedure significantly better than radiation therapy and that it should be the procedure of first choice.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9314368     DOI: 10.1016/s1051-0443(97)70660-2

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  28 in total

Review 1.  [Compression syndromes].

Authors:  J Wierecky; C Bokemeyer
Journal:  Internist (Berl)       Date:  2005-01       Impact factor: 0.743

Review 2.  Endovascular stenting to treat obstruction of the superior vena cava.

Authors:  Anthony F Watkinson; Tow Non Yeow; Clementine Fraser
Journal:  BMJ       Date:  2008-06-21

3.  Acute unilateral facial and orbital pain: an unusual presentation of superior vena cava obstruction.

Authors:  Shawn Foo; Iain Lawrie; Philip G Wiles
Journal:  J R Soc Med       Date:  2011-09       Impact factor: 5.344

4.  Superior vena cava syndrome presenting as position-dependent periorbital oedema.

Authors:  A L Nguyen; H Belderbos; J G van Harten; L Wijne
Journal:  BMJ Case Rep       Date:  2018-06-20

Review 5.  [Diagnostic and therapeutic management of the superior vena cava syndrome].

Authors:  W Dempke; C Behrmann; C Schöber; T Büchele; A Grothey; H J Schmoll
Journal:  Med Klin (Munich)       Date:  1999-12-15

Review 6.  Palliative procedures in lung cancer.

Authors:  Emi Masuda; Akhilesh K Sista; Bradley B Pua; David C Madoff
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

7.  Successful treatment of malignant superior vena cava syndrome using a stent-graft.

Authors:  Dong Il Gwon; Sang Hyun Paik
Journal:  Korean J Radiol       Date:  2012-03-07       Impact factor: 3.500

8.  Endoluminal treatment for venous vascular complications of malignant tumors.

Authors:  Liang Xiao; Jia-Jie Tong; Jing Shen
Journal:  Exp Ther Med       Date:  2012-05-24       Impact factor: 2.447

9.  Superior vena cava syndrome caused by a malignant tumor: a retrospective single-center analysis of 124 cases.

Authors:  Karin Hohloch; Nick Bertram; Lorenz Trümper; Tim Beissbarth; Frank Griesinger
Journal:  J Cancer Res Clin Oncol       Date:  2014-07-06       Impact factor: 4.553

10.  Endovascular stenting as a first choice for the palliation of superior vena cava syndrome.

Authors:  Yu-Il Kim; Kyu-Sik Kim; Young-Chun Ko; Chang-Min Park; Sung-Chul Lim; Young-Chul Kim; Kyung-Ok Park; Woong Yoon; Yoon-Hyun Kim; Jae-Kyu Kim; Sung-Ja Ahn
Journal:  J Korean Med Sci       Date:  2004-08       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.